Quality of Life in Glioblastoma Not Worsened by Tumor-Treating Fields Plus Temozolomide
TTFields therapy was associated with significantly greater physical and emotional functioning.
PVSRIPO is a prototypic oncolytic recombinant polio virus vaccine that recognizes the poliovirus receptor CD155, which is widely expressed in neoplastic cells of solid tumors.
The FDA has granted full approval of Avastin for the treatment of glioblastoma.
Treatment with lomustine plus bevacizumab does not show a survival advantage over treatment with lomustine alone in patients with glioblastoma.